|
Originally published In Press as doi:10.1074/jbc.M403753200 on September 13, 2004
J. Biol. Chem., Vol. 279, Issue 49, 51601-51611, December 3, 2004
Regulation of ADAM12 Cell-surface Expression by Protein Kinase C *
Christina Sundberg ¶,
Charles Kumar Thodeti ,
Marie Kveiborg ¶,
Christer Larsson||,
Peter Parker**,
Reidar Albrechtsen , and
Ulla M. Wewer 
From the
Institute of Molecular Pathology, University of Copenhagen, Frederik V's Vej 11, Copenhagen, DK-2100, Denmark, ||Department of Laboratory Medicine, University Hospital, Lund University, S-20502 Malmö, Sweden, and **Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom
The ADAM (a disintegrin and metalloprotease) family consists of multidomain cell-surface proteins that have a major impact on cell behavior. These transmembrane-anchored proteins are synthesized as proforms that have (from the N terminus): a prodomain; a metalloprotease-, disintegrin-like-, cysteine-rich, epidermal growth factor-like, and transmembrane domain; and a cytoplasmic tail. The 90-kDa mature form of human ADAM12 is generated in the trans-Golgi through cleavage of the prodomain by a furin-peptidase and is stored intracellularly until translocation to the cell surface as a constitutively active protein. However, little is known about the regulation of ADAM12 cell-surface translocation. Here, we used human RD rhabdomyosarcoma cells, which express ADAM12 at the cell surface, in a temporal pattern. We report that protein kinase C (PKC) induces ADAM12 translocation to the cell surface and that catalytic activity of PKC is required for this translocation. The following results support this conclusion: 1) treatment of cells with 0.1 µM phorbol 12-myristate 13-acetate (PMA) enhanced ADAM12 cell-surface immunostaining, 2) ADAM12 and PKC could be co-immunoprecipitated from membrane-enriched fractions of PMA-treated cells, 3) RD cells transfected with EGFP-tagged, myristoylated PKC expressed more ADAM12 at the cell surface than did non-transfected cells, and 4) RD cells transfected with a kinase-inactive PKC mutant did not exhibit ADAM12 cell-surface translocation upon PMA treatment. Finally, we demonstrate that the C1 and C2 domains of PKC both contain a binding site for ADAM12. These studies show that PKC plays a critical role in the regulation of ADAM12 cell-surface expression.
Received for publication, April 5, 2004
, and in revised form, September 9, 2004.
* This study was supported in part by grants from the Danish Cancer Society, Danish Medical Research Council, Neye Foundation, Velux, Novo Nordisk, Munksholm, Friis, and Haensch Foundations, and by Medical Devices Agency and European Union grants, Quality of Life and Management of Living Resources (contract no. QLG1-CT-1999-00870, designated Genetic Resolution of Myopathies: European cluster [Myocluster]). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
¶ Supported by postdoctoral fellowships from the Danish Medical Research Council.
 Corresponding author. Tel.: 45-3532-6056; Fax: 45-3532-6081; E-mail: ullaw{at}pai.ku.dk.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. A. Kohutek, C. G. diPierro, G. T. Redpath, and I. M. Hussaini
ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C-{alpha} Dependent and Promotes Glioblastoma Cell Migration
J. Neurosci.,
April 8, 2009;
29(14):
4605 - 4615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bourd-Boittin, H. Le Pabic, D. Bonnier, A. L'Helgoualc'h, and N. Theret
RACK1, a New ADAM12 Interacting Protein: CONTRIBUTION TO LIVER FIBROGENESIS
J. Biol. Chem.,
September 19, 2008;
283(38):
26000 - 26009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sunesson, U. Hellman, and C. Larsson
Protein Kinase C{epsilon} Binds Peripherin and Induces Its Aggregation, Which Is Accompanied by Apoptosis of Neuroblastoma Cells
J. Biol. Chem.,
June 13, 2008;
283(24):
16653 - 16664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Frohlich, R. Albrechtsen, L. Dyrskjot, L. Rudkjaer, T. F. Orntoft, and U. M. Wewer
Molecular Profiling of ADAM12 in Human Bladder Cancer
Clin. Cancer Res.,
December 15, 2006;
12(24):
7359 - 7368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Godde, G. M. D'Abaco, L. Paradiso, and U. Novak
Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members
J. Cell Sci.,
August 15, 2006;
119(16):
3296 - 3305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. M. Wewer, M. Morgelin, P. Holck, J. Jacobsen, M. C. Lydolph, A. H. Johnsen, M. Kveiborg, and R. Albrechtsen
ADAM12 Is a Four-leafed Clover: THE EXCISED PRODOMAIN REMAINS BOUND TO THE MATURE ENZYME
J. Biol. Chem.,
April 7, 2006;
281(14):
9418 - 9422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kveiborg, C. Frohlich, R. Albrechtsen, V. Tischler, N. Dietrich, P. Holck, P. Kronqvist, F. Rank, A. M. Mercurio, and U. M. Wewer
A Role for ADAM12 in Breast Tumor Progression and Stromal Cell Apoptosis
Cancer Res.,
June 1, 2005;
65(11):
4754 - 4761.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|